Biosynex S.A.
$0.94▲ 5.62%(+$0.05)
TickerSpark Score
51/100
▌ Mixed
80
Valuation
20
Profitability
35
Growth
60
Health
60
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALBIO.PA research report →
52-Week Range43% of range
Low
$0.46
Current
$0.94
High
$1.57
Company Overviewwww.biosynex.com
About the company
Biosynex S. A. specializes in the development, manufacture, and worldwide distribution of rapid diagnostic solutions.
- CEO
- Larry Abensur
- IPO
- 2011
- Employees
- 515
- HQ
- Illkirch-Graffenstaden, FR
Price Chart
-22.31% · this period
Valuation
- Market Cap
- $17.33M
- P/E
- -0.22
- P/S
- 0.18
- P/B
- 0.50
- EV/EBITDA
- 10.80
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -3.78%
- Op Margin
- -4.94%
- Net Margin
- -61.13%
- ROE
- -146.86%
- ROIC
- -4.09%
Growth & Income
- Revenue
- $95.20M · -5.93%
- Net Income
- $-58,200,000 · -34.41%
- EPS
- $-3.10 · 6.63%
- Op Income
- $-4,700,000
- FCF YoY
- 42.69%
Performance & Tape
- 52W High
- $1.57
- 52W Low
- $0.46
- 50D MA
- $0.95
- 200D MA
- $0.80
- Beta
- 0.83
- Avg Volume
- 59.25K
Get TickerSpark's AI analysis on ALBIO.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · ALBIO.PA
Our ALBIO.PA coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on ALBIO.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALBIO.PA report →Internal Compare
Similar companies
Peers in the same neighborhood.